DA Davidson Comments on Oracle’s Q1 Earnings (NYSE:ORCL)

Oracle Co. (NYSE:ORCLFree Report) – Stock analysts at DA Davidson issued their Q1 2026 EPS estimates for Oracle in a research report issued to clients and investors on Friday, June 13th. DA Davidson analyst G. Luria expects that the enterprise software provider will post earnings of $1.15 per share for the quarter. DA Davidson has a “Neutral” rating and a $170.00 price target on the stock. The consensus estimate for Oracle’s current full-year earnings is $5.00 per share. DA Davidson also issued estimates for Oracle’s FY2027 earnings at $6.06 EPS.

Oracle (NYSE:ORCLGet Free Report) last issued its quarterly earnings data on Wednesday, June 11th. The enterprise software provider reported $1.70 EPS for the quarter, topping analysts’ consensus estimates of $1.64 by $0.06. The company had revenue of $15.90 billion during the quarter, compared to the consensus estimate of $15.58 billion. Oracle had a net margin of 21.16% and a return on equity of 133.25%. Oracle’s revenue for the quarter was up 11.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.63 earnings per share.

A number of other equities analysts also recently issued reports on ORCL. Monness Crespi & Hardt raised Oracle from a “sell” rating to a “neutral” rating in a research report on Monday, March 3rd. Morgan Stanley reaffirmed a “positive” rating on shares of Oracle in a research report on Monday, June 9th. Royal Bank of Canada upped their price target on Oracle from $145.00 to $195.00 and gave the stock a “sector perform” rating in a research report on Thursday, June 12th. JPMorgan Chase & Co. upped their price target on Oracle from $135.00 to $185.00 and gave the stock a “neutral” rating in a research report on Thursday, June 12th. Finally, The Goldman Sachs Group reaffirmed a “neutral” rating and set a $195.00 price target (up from $145.00) on shares of Oracle in a research report on Friday. Eleven analysts have rated the stock with a hold rating, twenty-one have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Oracle has an average rating of “Moderate Buy” and a consensus target price of $194.32.

Get Our Latest Stock Analysis on ORCL

Oracle Stock Performance

Shares of ORCL stock opened at $210.94 on Monday. The business’s fifty day simple moving average is $154.61 and its 200-day simple moving average is $160.49. The company has a market cap of $589.98 billion, a PE ratio of 51.57, a PEG ratio of 3.46 and a beta of 1.32. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 5.65. Oracle has a 12-month low of $118.86 and a 12-month high of $216.60.

Oracle Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 24th. Investors of record on Thursday, July 10th will be given a dividend of $0.50 per share. The ex-dividend date is Thursday, July 10th. This represents a $2.00 annualized dividend and a dividend yield of 0.95%. Oracle’s dividend payout ratio (DPR) is presently 46.08%.

Insider Buying and Selling

In other Oracle news, Director Naomi O. Seligman sold 2,000 shares of the stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $145.81, for a total value of $291,620.00. Following the completion of the sale, the director now owns 34,630 shares in the company, valued at approximately $5,049,400.30. This represents a 5.46% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Vice Chairman Jeffrey Henley sold 400,000 shares of the stock in a transaction dated Thursday, June 12th. The shares were sold at an average price of $190.42, for a total transaction of $76,168,000.00. Following the completion of the sale, the insider now owns 1,097,576 shares of the company’s stock, valued at approximately $209,000,421.92. The trade was a 26.71% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 427,366 shares of company stock worth $80,183,723 in the last 90 days. Insiders own 42.20% of the company’s stock.

Institutional Trading of Oracle

A number of hedge funds have recently bought and sold shares of ORCL. Capital & Planning LLC raised its holdings in Oracle by 0.5% in the 4th quarter. Capital & Planning LLC now owns 15,727 shares of the enterprise software provider’s stock valued at $2,621,000 after acquiring an additional 81 shares during the last quarter. Brighton Jones LLC increased its holdings in shares of Oracle by 189.3% during the 4th quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider’s stock worth $25,593,000 after buying an additional 100,494 shares during the last quarter. Union Bancaire Privee UBP SA acquired a new stake in shares of Oracle during the 4th quarter worth approximately $51,084,000. Revolve Wealth Partners LLC increased its holdings in shares of Oracle by 8.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider’s stock worth $903,000 after buying an additional 404 shares during the last quarter. Finally, WealthPLAN Partners LLC increased its holdings in shares of Oracle by 22.0% during the 4th quarter. WealthPLAN Partners LLC now owns 3,843 shares of the enterprise software provider’s stock worth $640,000 after buying an additional 693 shares during the last quarter. Institutional investors and hedge funds own 42.44% of the company’s stock.

About Oracle

(Get Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Featured Stories

Earnings History and Estimates for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.